StockData
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. (OVID) stock

OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$2.22−0.18 (-7.50%)

Close on Nov 17, 2026Market cap $433.56MP/E –Yield –

Ovid Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Ovid Therapeutics's total assets was $231.97M at Jun 30, 2026. For fiscal 2025 it was $150.93M, up 63.8% from the year before. The highest annual figure on record is $194.54M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$150.93M+63.8%
FY2024Dec 31, 2024$92.17M-36.0%
FY2023Dec 31, 2023$144.03M-7.2%
FY2022Dec 31, 2022$155.27M-20.2%
FY2021Dec 31, 2021$194.54M+156.2%
FY2020Dec 31, 2020$75.93M-6.1%
FY2019Dec 31, 2019$80.84M+69.7%
FY2018Dec 31, 2018$47.65M-46.7%
FY2017Dec 31, 2017$89.46M+68.7%
FY2016Dec 31, 2016$53.03M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$231.97M+199.6%
Q1 FY2026Mar 31, 2026$225.63M+176.3%
Q4 FY2025Dec 31, 2025$150.93M+63.8%
Q3 FY2025Sep 30, 2025$63.85M-37.8%
Q2 FY2025Jun 30, 2025$77.43M-34.4%
Q1 FY2025Mar 31, 2025$81.65M-38.0%
Q4 FY2024Dec 31, 2024$92.17M-36.0%
Q3 FY2024Sep 30, 2024$102.65M-17.9%
Q2 FY2024Jun 30, 2024$118.09M-13.3%
Q1 FY2024Mar 31, 2024$131.61M-8.2%
Q4 FY2023Dec 31, 2023$144.03M-7.2%
Q3 FY2023Sep 30, 2023$125.03M-24.2%
Q2 FY2023Jun 30, 2023$136.23M-23.2%
Q1 FY2023Mar 31, 2023$143.37M-25.0%
Q4 FY2022Dec 31, 2022$155.27M-20.2%
Q3 FY2022Sep 30, 2022$165.03M-20.3%
Q2 FY2022Jun 30, 2022$177.33M-18.7%
Q1 FY2022Mar 31, 2022$191.10M-19.5%
Q4 FY2021Dec 31, 2021$194.54M+156.2%
Q3 FY2021Sep 30, 2021$207.09M+126.1%
Q2 FY2021Jun 30, 2021$218.00M+380.6%
Q1 FY2021Mar 31, 2021$237.46M+284.7%
Q4 FY2020Dec 31, 2020$75.93M-6.1%
Q3 FY2020Sep 30, 2020$91.60M+125.1%
Q2 FY2020Jun 30, 2020$45.36M-17.4%
Q1 FY2020Mar 31, 2020$61.72M-7.4%
Q4 FY2019Dec 31, 2019$80.84M+69.7%
Q3 FY2019Sep 30, 2019$40.69M-32.6%
Q2 FY2019Jun 30, 2019$54.91M-20.0%
Q1 FY2019Mar 31, 2019$66.66M-15.3%
Q4 FY2018Dec 31, 2018$47.65M-46.7%
Q3 FY2018Sep 30, 2018$60.39M-38.1%
Q2 FY2018Jun 30, 2018$68.61M-36.5%
Q1 FY2018Mar 31, 2018$78.67M+66.7%
Q4 FY2017Dec 31, 2017$89.46M+68.7%
Q3 FY2017Sep 30, 2017$97.57M–
Q2 FY2017Jun 30, 2017$108.01M–
Q1 FY2017Mar 31, 2017$47.20M–
Q4 FY2016Dec 31, 2016$53.03M–

More Ovid Therapeutics figures

See a number that looks wrong?